France Reverse-Switches Flurbiprofen Against Backdrop Of NSAID Concerns
Executive Summary
France has unexpectedly reverse switched to prescription status flurbiprofen, the active ingredient in Reckitt's Strefen. The move comes shortly after the country's medicines agency warned of serious adverse events related to certain NSAIDs.
You may also be interested in...
EU Warns Flurbiprofen Can Potentially Mask Infection Symptoms
Popular OTC sore throat treatment flurbiprofen can possibly mask the symptoms of infection and lead to treatment delays, according to EU medicines regulators. Products sold in the EU containing flurbiprofen will soon be required to carry information warning patients and healthcare professionals about this risk.
Sore Throat Drugs Heading Behind The Counter In France Over Safety Fears
France's drugs agency wants to restrict sales of OTC sore throat treatments marketed by Sanofi and others to behind the pharmacy counter due to fears of potential adverse events.
France's ANSM Moves Paracetamol, Ibuprofen And Aspirin Behind The Counter
France restricts sales of medicines containing paracetamol, ibuprofen and aspirin to behind the pharmacy counter due to safety concerns.